Globus Medical (GMED) news
Recent news
GLOBUS Maritime - Prospectus filed for resale of up to 1.3 mln common shares by selling shareholder - SEC filing
Globus Maritime Limited (NASDAQ: GLBS) has filed a prospectus with the U.S. Securities and Exchange Commission (SEC) for the resale of up to 1.3 million common shares by a selling shareholder, according to a recent SEC filing . The filing is part of the company’s ongoing efforts to manage its…
AInvest Wire · Oct 2, 2026Globeus Medical, Inc.: RBC cuts target price to $85 from $115
Globus Medical, Inc. (NYSE: GMED) recently saw its stock price trade at $75.70 as of September 30, 2026, following a mixed set of analyst updates and strong quarterly earnings performance. On July 13, 2026, Royal Bank of Canada (RBC) cut its target price for GMED from $115 to $85, while maintaining…
AInvest Wire · Oct 1, 2026Prim - Formalizes agreement to extend distribution contract with Globus Medical
Globus Medical, Inc. has formalized an agreement to extend its distribution contract with Prim, a move that underscores the ongoing collaboration between the two entities in the medical device supply chain. The terms of the agreement align with the company’s standard purchase order terms and…
AInvest Wire · Sep 23, 2026Globus Medical announces acquisition of Higgs Boson Health to transform healthcare experience through AI-driven digital solutions
Globus Medical (NYSE: GMED) has announced the acquisition of Higgs Boson Health, a digital health company specializing in AI-driven platforms designed to enhance the healthcare experience for patients and providers. This strategic move aligns with Globus Medical’s broader initiative to integrate…
AInvest Wire · Aug 26, 2026Globus Medical outlook FY adjusted EPS USD 4.95-5.05
Globus Medical has provided an updated outlook for fiscal year adjusted earnings per share (EPS), projecting a range of $4.95 to $5.05 [1]. This guidance reflects the company’s current financial expectations and incorporates anticipated performance across its business segments. The updated forecast…
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.